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Anaemia is a common complication of chemotherapy. Since
anaemia can lead to different symptoms, such as fatigue, respi-
ratory distress and chest pain, thereby diminishing physical
capacity and quality of life, it is generally accepted that anaemia
should be corrected. Treatment options include red blood cell
transfusion (RBCT), erythropoietin (EPO) administration or a
combination of both. OBJECTIVE: Our objective was to carry
out a cost-effectiveness analysis of treatment with EPO (ery-
thropoietin alpha) compared to traditional treatment with RBCT
for patients with chemotherapy-induced anaemia in Sweden
from a hospital perspective. METHOD: We developed a model
for Swedish treatment practice (patient characteristics, response
rates, and RBC transfusion data taken from Swedish observa-
tional data), and Swedish unit costs, based on a model commis-
sioned by the National Institute of Clinical Excellence, UK.
Incremental costs associated with EPO treatment compared to
treatment with RBCT, were estimated. Different cancer types and
populations were modelled by varying initial Hb, response and
mortality rates. RESULTS: The model results on costs corre-
spond well to real world data from three big hospitals in Sweden.
Average costs per patient are SEK34,900 for EPO and SEK
12,400 for RBCT. The cost per QALY gained from admini-
stration of EPO assuming a survival beneﬁt attributable to EPO
treatment was estimated at SEK 120,000. The survival beneﬁt
from EPO is debated, and has a major impact of the results.
Excluding this beneﬁt gives an estimated cost of SEK 365,000
per QALY. EPO treatment is most cost-effective in patients with
initial Hb of 9–10 g/dl. The cost-effectiveness-ratio is also 
moderately sensitive to changes in the response rate to EPO,
baseline mortality, the cost of EPO and the estimated QALY gain 
from EPO administration. CONCLUSION: The estimated cost
per QALY falls well within the range acceptable in Sweden. 
The cost-effectiveness of EPO varies between different cancer
populations.
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OBJECTIVES: Organized nationwide screening programme for
cervical cancer was introduced in Hungary in 2003. Women
between the ages 25–65 are invited by a personal letter and a 3
years screening interval has been applied. Before the implemen-
tation of organized screening programme there was an oppor-
tunistic screening. The aim of this study is to analyse the three
year screening rate (attendance or coverage) of the organized
programme according to counties. METHODS: The data derive
from the ﬁnancial database of the National Health Insurance
Fund Administration (OEP) of Hungary covering the period 
of 2000–2005. We calculated the three-year screening rate of 
two periods: 2000–2002 without and 2003–2005 with organized
screening programme for women aged 25–64. Screening is
deﬁned with cytological examination of Papanicolau smear and
includes all smears taken either within or outside of the orga-
nized programme. RESULTS: The age speciﬁc screening rate of
women aged 25–64 years increased from 48, 45% in 2000–2002
without organized screening programme to 52, 65% in
2003–2005 following the introduction of organized screening
programme. There were signiﬁcant differences in the screening
rate (attendance or coverage) among counties with the highest
values in county Baranya (58, 59%), Tolna (55, 35%), Borsod-
Abaúj-Zemplén (54, 61%) and the lowest values in county 
Jász-Nagykun-Szolnok (40, 06%), Vas (41, 47%), Veszprém (42,
52%). From 2000–2002 to 2003–2005 we found the largest
increase in the following counties: Veszprém (14.35 percent
point), Borsod-Abaúj-Zemplén (7.69 percent point), Békés (5.46
percent point). The gap between the counties with the highest
and lowest screening rate decreased. CONCLUSIONS: We
found signiﬁcant differences in the screening rate among coun-
ties, which should be reduced. However, the introduction of
organized cervical screenig programme lead to closing up the
between county differences.
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OBJECTIVES: To develop a simulation model for estimating the
future impact on deaths and new bowel cancer registrations
under alternative bowel cancer screening programme implemen-
tation and design strategies. METHODS: The UK began phasing
in a faecal occult blood test (FOBT) bowel cancer screening pro-
gramme for all persons aged 60–69 in April 2006. We ﬁtted a
novel Bayesian autoregressive age-period-cohort model (Bray
2002) to bowel cancer incidence and mortality data in England
1993–2003/4 (ONS/GAD 2005) that uses parameters efﬁciently
and provides credible intervals for assessing projection uncer-
tainty. We then used the model with results taken from separate
cohort-based bowel cancer natural history modelling (Tappen-
den 2004) and government age- and gender-speciﬁc population
projections to estimate bowel cancer incidence and mortality for
2003–2016 under various bowel cancer screening program
design and implementation strategies. RESULTS: The model ﬁt
the data well. We estimate that phased implementation of the
UK bowel screening program will result in 2440 undetected
cancers (95% CI 808–10,160) and 244 (95% CI 114–610) addi-
tional bowel cancer deaths in 2006–8. Further, a programme
combining FOBT with ﬂexible sigmoidoscopy would detect an
estimated 737 (95% CI 207–3917) more bowel cancers and
prevent 389 (95% CI 156–1168) more deaths than FOBT alone.
CONCLUSIONS: This model provides a valuable tool for 
generating point and interval estimates of the long-term popu-
lation impact of alternative bowel cancer screening program
implementation and design strategies, and can be updated as 
new information arises. Projection uncertainty arises from the
model itself and the disease natural history information used to
inform it.
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OBJECTIVES: To describe factors inﬂuencing inequitable access
to radiation therapy among cancer patients in Thailand by
exploring the current situation and problems of both demand
and supply sides after implementation of the policy on universal
coverage. The study aimed to improve efﬁciency in health
resource allocation and equitable access to expensive health ser-
vices by using radiation therapy as the case study. METHODS:
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Both quantitative and qualitative approaches were employed. A
census of 25 radiation therapy units (both public and private
facilities) and 72 radiation therapists around the country were
carried out. Semi-structured interviews with 1500 sampled
cancer patients and in-depth interviews with 12 purposively
selected radiation therapists were conducted. RESULTS: Lacking
of vital human resources, both radiation therapists and medical
physicists, is a serious and urgent problem of the radiation
therapy services under the Ministry of Public Health (MOPH).
There was no public facility under MOPH passing the minimum
standard in terms of the appropriate amount of radiation thera-
pists, whilst only 20% of them passed the minimum standard
for medical physicists. Mal-distribution of radiation therapy
facilities favoring Bangkok and big cities, inability to pay for
traveling costs and lacking of health insurance among poor
cancer patients were crucial factors inﬂuencing equitable access
to radiation therapy services. Interviews from radiation thera-
pists support that there is an urgent need to solve the shortage
of human resources for radiation therapy services and improve
the quality of care. CONCLUSIONS: Factors of both demand
and supply sides inﬂuence the problems of inequitable access to
radiation therapy in Thailand. The removal of ﬁnancial barriers
under universal coverage can not solely solve the problem of
inequitable access to such expensive health services. Effective
short-term and long-term measures require actively participation
and concerted efforts of various stakeholders.
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OBJECTIVE: To estimate the short-term impact of adopting the
UK bowel cancer screening programme on cost and outcomes.
METHODS: The UK National Health Service (NHS) recently
announced a bowel cancer screening programme consisting of
biennial faecal occult blood testing (FOBT) to be phased in start-
ing April 2006 (25% of the potential population screened in
years 1 and 2 and 50% in year 3). Selection of this screening
strategy was based on an independent economic evaluation 
(Tappenden 2004) that ranked it fourth out of ﬁve alternative
strategies in terms of cost effectiveness. We ﬁtted a Bayesian
autoregressive age-period-cohort model to data of bowel cancer
incidence in the UK 1993–2004/5 to estimate the cost savings
and impact on outcomes resulting from phased implementation,
and from choosing a less expensive, less cost-effective screening
programme. UK costings were derived from the previous Tap-
penden 2004 analysis. RESULTS: We estimate that in the period
2006–2009, phased implementation of the chosen biennial
FOBT programme will save GBP146 million compared to full
implementation, but will also result in 2440 fewer bowel cancer
cases detected. Adoption of the most cost-effective screening
strategy would increase the number of cancers detected by 737,
and would cost GBP1.49 million less to implement than the
chosen option at the governmental phased rates in this three-year
period. When compared to no screening, it costs GBP23,679 to
detect a bowel cancer case using biennial FOBT in the age group
60–69. In the same age group, using the more cost effective strat-
egy of FSIG plus biennial FOBT it costs GBP18,534 to detect a
bowel cancer case. CONCLUSION: Affordability and service
impact appeared to be more important factors than cost effec-
tiveness in selecting a bowel cancer-screening program for the
UK.
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OBJECTIVE: The primary goal of breast cancer screening tests
is to ﬁnd cancer at an early stage before a person has any symp-
toms. Evidence suggests that screening examinations such as
mammography and clinical breast examinations (CBE) are effec-
tive in early detection of breast cancer. Physician recommenda-
tion is an important reason many women undergo screening.
This study examined the physician and patients related factors
associated with physician recommendations for breast cancer
screening in the United States (US) outpatient settings.
METHODS: This cross-sectional study used data from the
National Ambulatory Medical Care Survey (NACMS) from
1996¨C2004. Women aged °Y´40 years were included in the study
sample. Multivariate logistic regression analyses were used to
study the objectives. RESULTS: Weighted analysis indicated that
physicians performed 198 million CBEs and made 110 million
mammography recommendations over the study period
(1996–2004). Patients’ age, duration of visits, history of previ-
ous breast cancer diagnosis, and source of insurance were sig-
niﬁcant predictors of screening recommendations in this
population. Obstetricians and gynecologists were more likely to
perform a CBE and recommend mammography than other spe-
cialty physicians. CONCLUSIONS: These ﬁndings indicated that
there were certain disparities regarding the physician recom-
mendations of breast cancer screening for women in the US out-
patient settings.
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OBJECTIVES: Organized nationwide screening programme for
cervical cancer was introduced in Hungary in 2003. Women
between the ages 25–65 are invited by a personal letter and a 3
years screening interval has been applied. Before the implemen-
tation of organized screening programme there was an oppor-
tunistic screening. The aim of this study is to analyse both the
annual and three year screening rate (attendance) of the orga-
nized programme. METHODS: The data derive from the ﬁnan-
cial database of the National Health Insurance Fund
Administration (OEP) of Hungary covering the period of
2000–2005. First we calculated the annual screening rate than
we compared the three-year screening rate of two periods:
2000–2002 without and 2003–2005 with organized screening
programme. Screening is deﬁned with cytological examination of
Papanicolau smear and includes all smears taken either within
or outside of the organized programme. RESULTS: The annual
screening rate of women for all age groups varied between
15.5% and 16.8% during the 6 years between 2000–2005. The
age speciﬁc screening rate of women aged 25–64 years varied
between 21.8% and 24.3% between 2000–2005. The three-year
screening rate of women for all age groups was 31.4% in
2000–2002 and 32.9% in 2003–2005. The age speciﬁc screen-
ing rate of women in the target population aged 25–64 years
increased from 48, 45% in 2000–2002 without organized
screening programme to 52, 65% in 2003–2005 following the
